August 09 | 6 Strong Buy Health Technology Stocks On Watchlist

This is a must read [Did Biden Bet the Future of America on the "Lithium Triangle"?]() [Discover the one company set to break China's grip on lithium.]() --------------------------------------------------------------- Dear Reader, We have identified 6 'Strong Buy' Health Technology Trade Stocks that you might want to keep an eye on....Keep in mind, these are very volatile stocks so please do your own research before you make any investments. We are not recommending these stocks but they are certainly getting positive attention from analysts. --------------------------------------------------------------- [Potential Gold Rush For Investors Sparked By USA Vs. China Trade War](=) =Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump... China's Monopoly Is About To Crumble... [And Create A Potential Boom For Investors](=) = --------------------------------------------------------------- See the list below. [Pliant Therapeutics, PLRX](=) - Buy to Strong Buy [TipRanks.com](=) also reports that [Pliant Therapeutics]() currently has 8 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $43.88. The target pricing ranges from a high forecast of $54.00 down to a low forecast of $33.00. [Pliant Therapeutics (PLRX)](’s last closing price was $$20.67 which would put the average price target at 111.80% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]( ----------------------------------------------------- [Shockwave Medical, SWAV]() - Buy to Strong Buy [TipRanks.com]() also reports that [Shockwave Medical]( currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $190.33. The target pricing ranges from a high forecast of $245.00 down to a low forecast of $155.00. [Shockwave Medical (SWAV)]()’s last closing price was $$264.06 which would put the average price target at -8.51% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]( ----------------------------------------------------- --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"](=) = [Click here]() for the name of the one ticker you need to protect yourself. --------------------------------------------------------------- [Royalty Pharma, RPRX]( - Buy to Strong Buy [TipRanks.com]() also reports that [Royalty Pharma]( currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $53.17. The target pricing ranges from a high forecast of $60.00 down to a low forecast of $47.00. [Royalty Pharma (RPRX)](’s last closing price was $$43.36 which would put the average price target at 22.62% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bearish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]( ----------------------------------------------------- [Myovant Sciences, MYOV]( - Buy to Strong Buy [TipRanks.com]( also reports that [Myovant Sciences]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $20.40. The target pricing ranges from a high forecast of $27.00 down to a low forecast of $11.00. [Myovant Sciences (MYOV)](=)’s last closing price was $$16.33 which would put the average price target at 24.92% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a buy rating. [Click for chart >>](=) ----------------------------------------------------- --------------------------------------------------------------- [Wall Street Icon Anthony Scaramucci Has Critical Announcement For All Crypto Investors](=) =3 advanced cryptocurrencies trading for pennies on the dollar are now on the move. Which is why Skybridge Capital CEO Anthony Scaramucci is broadcasting a one-time strategy session showing folks how to get in while prices are exceedingly cheap. [Watch it here.]() --------------------------------------------------------------- [Lantheus, LNTH](=) - Buy to Strong Buy [TipRanks.com](=) also reports that [Lantheus]() currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $100.33. The target pricing ranges from a high forecast of $110.00 down to a low forecast of $91.00. [Lantheus (LNTH)]()’s last closing price was $$81.44 which would put the average price target at 28.93% upside. Based on 3rd party rating services including: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]() = ----------------------------------------------------- [Aerie Pharma, AERI]() - Buy to Strong Buy [TipRanks.com]( also reports that [Aerie Pharma](=) currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $15.33. The target pricing ranges from a high forecast of $20.00 down to a low forecast of $12.00. [Aerie Pharma (AERI)](=)’s last closing price was $$10.94 which would put the average price target at 40.13% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Weak buy rating. [Click for chart >>]( = ----------------------------------------------------- Pricing & Percentages as of approximately 10:00am EST. [TipRanks.com]( tracks and measures the performance of over 50,000 financial experts. The TipRanks Star Ranking TM is calculated based on expert success rate, average return and statistical significance. [Get more from TipRanks.com here >>]( --------------------------------------------------------------- [5X Potential Growth By 2030? Is This Little-Known Market About To Explode?](=) =It's used for our BELOVED Air Force's fighter jets, cell phones, and wind turbines. And soon, you're going to hear about it everywhere... because according to renowned intelligence reports... [Demand Will EASILY 5X By 2030! (Discover It HERE!)](=) --------------------------------------------------------------- [Unsubscribe](=) Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954